Association of increased cortical soluble Aβ42 levels with diffuse plaques after severe brain injury in humans

Archives of Neurology

Volumn 64, Issue 4, 2007, Pages 541-544

  DeKosky, Steven T ^a   Abrahamson, Eric E ^a   Ciallella, John R ^a   Paljug, William R ^a   Wisniewski, Stephen R ^a   Clark, Robert S B ^a   Ikonomovic, Milos D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PLAQUE FORMING CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SYNAPSE; TEMPORAL CORTEX;

EID: 34247137869     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.4.541     Document Type: Article

References (26)

1. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351-357.
2. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging. 1992;13:179-189.
3. Roberts GW, Gentleman SM, Lynch A, et al. β Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994;57:419-425.
4. Ciallella JR, Ikonomovic MD, Paljug WR, et al. Changes in expression of amyloid precursor protein and interleukin-1β after experimental traumatic brain injury in rats. J Neurotrauma. 2002;19:1555-1567.
5. Murakami N, Yamaki T, Iwamoto Y, et al. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma. 1998;15:993-1003.
6. Gentleman SM, Nash MJ, Sweeting CJ, et al. β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury. Neurosci Lett. 1993;160:139-144.
7. Smith DH, Chen XH, Iwata A, Graham DI. Amyloid beta accumulation in axons after traumatic brain injury in humans. J Neurosurg. 2003;98:1072-1077.
8. Ikonomovic MD, Uryu K, Abrahamson EE, et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol. 2004;190:192-203.
9. Kay AD, Petzold A, Kerr M, et al. Alterations in cerebrospinal fluid apolipoprotein E and amyloid β-protein after traumatic brain injury. J Neurotrauma. 2003;20:943-952.
10. Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA. 2000;283:1571-1577.
11. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 2004;44:181-193.
12. Deshpande A, Mina E, Glabe C, Busciglio J. Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci. 2006;26:6011-6018.
13. Rockenstein E, Torrance M, Mante M, et al. Cerebrolysin decreases amyloid-β production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J Neurosci Res. 2006;83:1252-1261.
14. Maier M, Seabrook TJ, Lazo ND, et al. Short amyloid-beta (Aβ) immunogens reduce cerebral Aβ load and learning deficits in an Alzheimer's disease mouse model in the absence of an Aβ-specific cellular immune response. J Neurosci. 2006;26:4717-4728.
15. Wang J, Dickson DW, Trojanowski JQ, Lee VM. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol. 1999;158:328-337.
16. Gentleman SM, Greenberg BD, Savage MJ, et al. Aβ42 is the predominant form of amyloid β-protein in the brains of short-term survivors of head injury. Neuroreport. 1997;8:1519-1522.
17. Horsburgh K, Cole GM, Yang F, et al. β-Amyloid (Aβ)42(43), aβ42, aβ40 and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol. 2000;26:124-132.
18. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 1994;13:45-53.
19. McKenzie JE, Gentleman SM, Roberts GW, et al. Increased numbers of βAPP-immunoreactive neurones in the entorhinal cortex after head injury. Neuroreport. 1994;6:161-164.
20. Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Ann Neurol. 2006;59:512-519.
21. Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury. Nat Med. 1995;1:135-137.
22. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-E4 in patients with Alzheimer's disease. Neurology. 1995;45:555-557.
23. Povlishock JT, Jenkins LW. Are the pathobiological changes evoked by traumatic brain injury immediate and irreversible? Brain Pathol. 1995;5:415-426.
24. Mattson MP, Cheng B, Davis D, et al. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 1992;12:376-389.
25. Lesne S, Koh MT, Kotilinek L, et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature. 2006;440:352-357.
26. Cleary JP, Walsh DM, Hofmeister JJ, et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci. 2005;8:79-84.